Clinical outcome of 27 imatinib mesylate-resistant chronic myelogenous leukemia patients harboring a T315I BCR-ABL mutation.
Nicolini FE, Hayette S, Corm S, Bachy E, Bories D, Tulliez M, Guilhot F, Legros L, Maloisel F, Kiladjian JJ, Mahon FX, Lê QH, Michallet M, Roche-Lestienne C, Preudhomme C.
Nicolini FE, et al.
Haematologica. 2007 Sep;92(9):1238-41. doi: 10.3324/haematol.11369.
Haematologica. 2007.
PMID: 17768119
Free article.